Home
>
National Drug Code (NDC)
>
Cataflam
Cataflam - 0078-0436-05 - (diclofenac potassium)
Drug Information of Cataflam
| Product NDC: | 0078-0436 |
| Proprietary Name: | Cataflam |
| Non Proprietary Name: | diclofenac potassium |
| Active Ingredient(s): | 50 mg/1 & nbsp; diclofenac potassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, SUGAR COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cataflam
| Product NDC: | 0078-0436 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020142 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931124 |
Package Information of Cataflam
| Package NDC: | 0078-0436-05 |
| Package Description: | 100 TABLET, SUGAR COATED in 1 BOTTLE (0078-0436-05) |
NDC Information of Cataflam
| NDC Code | 0078-0436-05 |
| Proprietary Name | Cataflam |
| Package Description | 100 TABLET, SUGAR COATED in 1 BOTTLE (0078-0436-05) |
| Product NDC | 0078-0436 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diclofenac potassium |
| Dosage Form Name | TABLET, SUGAR COATED |
| Route Name | ORAL |
| Start Marketing Date | 19931124 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | DICLOFENAC POTASSIUM |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
